Healthcare
Live Price
Offline$0.00002
+0.00% today
1Y Change
-60.00%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Ubiquitech Software Corp. (UBQU) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and down 60.0% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +726.1%, EPS growth of -71.3%, a dividend yield of 0.0%. What stands out right now is revenue +726.1%, EPS -71.3%, free cash flow -297.0% with operating margin -1.6% and ROIC -1.0%. Valuation is more restrained than many high-expectation growth names at price/sales 0.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines UBQU price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
UBQU
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
UBQU Max Drawdown
-80.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for UBQU and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$136.2K
-43.0% YoY
FY Net Income
-$618.9K
-121.1% YoY
Free Cash Flow
-$210.2K
+73.3% YoY
Revenue Growth
+726.1%
EPS Growth
-71.3%
Gross Margin
23.1%
Net Margin
-13.9%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 2M | 224K | 282K | 239K | 136K |
| Gross Profit | 391K | -6K | -26K | 17K | -100K |
| Operating Income | -104K | -119K | -395K | -82K | -443K |
| EBITDA | 664K | 871K | -390K | -77K | -553K |
| Net Income | 387K | 711K | -554K | -280K | -619K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 10K | -863 | 662 | 227 | 11K |
| Total Assets | 3M | 186K | 194K | 76K | 59K |
| Total Liabilities | 4M | 2M | 2M | 2M | 3M |
| Shareholder Equity | -953K | -1M | -2M | -2M | -3M |
| Total Debt | 2M | 1M | 2M | 2M | 1M |
| Net Debt | 2M | 1M | 2M | 2M | 1M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
182K
+76.9% YoY
Capital Expenditures
29K
Free Cash Flow
210K
+73.3% YoY
Key ratios
Gross Margin
23.1%
Operating Margin
-1.6%
Net Margin
-13.9%
ROE
16.9%
Debt / Equity
-2.79x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.